The fact
This nomination could impact pharmaceutical and biotech sectors.
Investors are assessing the implications for regulated companies.
Click the link to read an article on the topic:
This nomination could impact pharmaceutical and biotech sectors.
Investors are assessing the implications for regulated companies.